{"nct_id":"NCT01988662","title":"UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)","status":"COMPLETED","status_verified_date":"2017-03","start_date":"2014-04","start_date_type":null,"primary_completion_date":"2015-09","primary_completion_date_type":"ACTUAL","completion_date":"2015-09","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}